Revvity RVTY
NYSE RVTY
$146.80 +1.07 (+0.73%)
As of: Sep 17, 2026 · 3:59 PM EDT

Revvity (RVTY) Cash & Current Investments (2009 - 2026)

Revvity's (RVTY) quarterly Cash & Current Investments came in at $1.0 billion in Q3 2026, up 3.13% on a YoY basis from $991.8 million in Q3 2025, and up 18.9% quarter-over-quarter from $860.3 million in Q2 2026.

Analysis

Revvity (RVTY) Cash & Current Investments (2009 - 2026) Analysis & Trends

Revvity (RVTY) has reported Cash & Current Investments for 18 consecutive years, with $1.0 billion the latest figure, recorded in Q3 2026.

  • For the quarter ending Q3 2026, Cash & Current Investments rose 3.13% year-over-year to $1.0 billion; the trailing twelve-month figure through Jul 2026 stood at $1.0 billion (up 3.13% YoY), and the FY2025 full-year result was $919.9 million, down 20.93% from the prior year.
  • Cash & Current Investments advanced to $1.0 billion in Q3 2026 per RVTY's latest filing, from $860.3 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $2.5 billion in Q2 2023 and bottomed at $345.9 million in Q3 2022.
  • Historically, Cash & Current Investments has averaged $1.2 billion across 5 years, with a median of $1.0 billion in 2026.
  • The sharpest annual moves came in 2023 and 2025: Cash & Current Investments jumped 498.78% in 2023, then sank 49.25% in 2025.
  • Over 5 years, Cash & Current Investments stood at $400.7 million in 2022, then surged by 300.03% to $1.6 billion in 2023, then slipped by 27.43% to $1.2 billion in 2024, then retreated by 20.93% to $919.9 million in 2025, then climbed by 11.21% to $1.0 billion in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $1.0 billion, $860.3 million, and $919.9 million for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 4.06 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 4.35 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 1.76 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 1.17 Bn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 1.02 Bn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 264.71 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn 1.62 Bn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 1.01 Bn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 552.03 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn 217.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 5, 2026 1.02 Bn
Apr 5, 2026 860.32 Mn
Dec 28, 2025 919.86 Mn
Sep 28, 2025 931.39 Mn
Jun 29, 2025 991.85 Mn
Mar 30, 2025 1.14 Bn
Dec 29, 2024 1.16 Bn
Sep 29, 2024 1.23 Bn
Jun 30, 2024 1.95 Bn
Mar 31, 2024 1.70 Bn
Dec 31, 2023 1.60 Bn
Oct 1, 2023 1.43 Bn
Jul 2, 2023 2.07 Bn
Apr 2, 2023 2.46 Bn
Jan 1, 2023 454.36 Mn
Oct 2, 2022 400.74 Mn
Jul 3, 2022 345.86 Mn
Apr 3, 2022 654.76 Mn
Jan 2, 2022 603.32 Mn
Oct 3, 2021 472.37 Mn